Walmart aims to bring “everyday low prices” to medical care.
They announced the launch of a version of insulin that will be cheaper for people who don’t have health insurance or who can’t afford the cost of life-saving drugs.
“These products will save customers between 58% and 75% off the cash price of branded analog insulin products, saving up to $ 101 per branded vial or $ 251 per pack of branded FlexPens,” the company said in a new press release this week.
Starting this week, Walmart will be selling its own private label version of analog insulin (a newer, more reliable form of the drug) to anyone with a prescription. It will also be available at Sam’s Club in mid-July under the name ReliOn NovoLog.
The insulin costs about $ 73 for a vial or about $ 86 for a pack of pre-filled insulin pens.
CONNECTED: 100 years after the first diabetes breakthrough, Canadian scientists believe they have found a cure
“We know that many people with diabetes have difficulty managing the financial burden of this condition and we are focused on helping with affordable solutions,” said Dr. Cheryl Pegus, Executive Vice President, Walmart Health & Wellness. “We also know that this is a condition that disproportionately affects underserved populations.”
“With ReliOn NovoLog Insulin, we are adding a high-quality drug for diabetes to the already affordable ReliOn product line, and we are continuing our commitment to improving access and reducing treatment costs.”
CONNECTED: Could Electromagnetic Fields Treat Diabetes? These scientists think so
ReliOn products include own brands, lower-priced versions of blood glucose meters, lancets and other important components of diabetes management.
According to CNBC, US lawmakers have historically screened diabetes drug makers like Eli Lilly and French company Sanofi for price increases over the past two decades, prompting Sanofi to launch a limited price-cutting program.
Walmart worked directly with manufacturer Novo Nordisk to reduce costs.
POPULAR: Excited Scientists Breakthrough Type 2 Diabetes With First Glimpses Of How Proteins Work Behind Diseases
“We hope that this award will improve and hopefully revolutionize the accessibility and affordability of insulin,” said Dr. Cheryl Pegus, Executive Vice President of Health and Wellness at Walmart.
Save some money for your friends by sharing this on social media …